Asset Details
Do you wish to reserve the book?
Radioiodine for Thyroid Cancer — Is Less More?
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Radioiodine for Thyroid Cancer — Is Less More?
Do you wish to request the book?
Radioiodine for Thyroid Cancer — Is Less More?
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Radioiodine for Thyroid Cancer — Is Less More?
2012
Overview
In this issue of the
Journal,
Schlumberger et al.
1
and Mallick et al.
2
describe the administration of radioiodine (iodine-131) after total thyroidectomy in patients with low-risk thyroid cancer. Postsurgical treatment has long played an important role in the management of this increasingly common cancer.
2
In the United States, the incidence nearly tripled (from 2.7 to 7.7 cases per 100,000) from 1973 through 2002.
3
Similar increases have been reported in Europe.
4
Such increases appear to result largely from more frequent radiologic detection and subsequent fine-needle aspiration of small thyroid nodules, leading to the diagnosis of low-risk thyroid cancer.
Guidelines of the . . .
Publisher
Massachusetts Medical Society
